Document Detail


Multicentricity in resected occult bronchogenic squamous cell carcinoma.
MedLine Citation:
PMID:  8179385     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The frequency and the treatment of multicentricity in 127 patients with resected roentgenographically occult bronchogenic squamous cell carcinoma were studied. The cumulative rate and the incidence of postoperative metachronous multiple primary lung cancer were 0.11 at 5 years after initial operation and 0.022 per patient-year, respectively. The cumulative rate and the incidence of second primary lung cancer, which includes synchronous and subsequent metachronous cancer in patients with initial lung cancer, were 0.17 at 5 years after the initial operation and 0.041 per patient-year, respectively. The cumulative rate and the incidence of third primary lung cancer in patients with second primary lung cancer were 0.47 at 5 years, which was significantly higher (p = 0.05) than that of second primary lung cancer, and 0.11 per patient-year, respectively. In all 12 patients with synchronous multiple primary lung cancer, no recurrence was observed after treatment, but 3 had subsequent multiple primary lung cancer. Among the 13 patients with postoperative metachronous multiple primary lung cancer, recurrence was observed in 1 of the 6 patients who underwent resection and in 2 of the 4 patients treated with laser or radiation therapy or both. The overall survival rate at 5 years after initial operation in patients with solitary and those with multicentric occult bronchogenic squamous cell carcinomas was 0.90 and 0.59, respectively.
Authors:
Y Saito; M Sato; M Sagawa; K Kanma; S Takahashi; K Usuda; N Nagamoto; C Endo; Y Chen; A Sakurada
Related Documents :
18461365 - Establishment of a new method, transcription-reverse transcription concerted reaction, ...
10884725 - Characteristics of small lung cancers invisible on conventional chest radiography and d...
7434145 - Social isolation in lung cancer patients.
12375015 - Expression of drug resistance gene products during progression of lung carcinomas.
24040285 - Integrative bioinformatics links hnf1b with clear cell carcinoma and tumor-associated t...
12684395 - Zd1839, a specific epidermal growth factor receptor (egfr) tyrosine kinase inhibitor, i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  57     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-06-08     Completed Date:  1994-06-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1200-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Thoracic Surgery, Tohoku University, Sendai, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Bronchogenic / mortality,  pathology*,  radiography,  surgery
Carcinoma, Squamous Cell / mortality,  pathology*,  radiography,  surgery
Humans
Lung Neoplasms / mortality,  pathology*,  radiography,  surgery
Male
Neoplasms, Multiple Primary* / mortality,  radiography,  surgery
Survival Rate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH.
Next Document:  Intraoperative imprint cytology for evaluation of mediastinal lymphadenopathy.